4//SEC Filing
Lauterbach Sandra Leigh 4
Accession 0001209191-10-007933
CIK 0001006281other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:24 PM ET
Size
5.9 KB
Accession
0001209191-10-007933
Insider Transaction Report
Form 4
Lauterbach Sandra Leigh
VP, Sales & Commercial Affairs
Transactions
- Award
Stock Options (Right to Buy)
2010-02-07+160,000→ 160,000 totalExercise: $6.81Exp: 2020-02-07→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The options vest over a four-year period. The first 25% of the options vest on the first anniversary of the grant date and the remaining 75% of the options vest in 12 equal tranches on a quarterly basis during the subsequent three- year period.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001479218
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:24 PM ET
- Size
- 5.9 KB